AU Patent

AU2019206022A1 — Abuse-resistant mucoadhesive devices for delivery of buprenorphine

Assigned to Biodelivery Sciences International Inc · Expires 2019-08-01 · 7y expired

What this patent protects

The present invention provides abuse deterrent mucoadhesive devices for delivery of buprenorphine. Each device comprises a mucoadhesive layer and a backing layer, and the pH in each layer is selected, such that absorption of buprenorphine is maximized. MUCOAbiESIVE , <.,xiMUCO…

USPTO Abstract

The present invention provides abuse deterrent mucoadhesive devices for delivery of buprenorphine. Each device comprises a mucoadhesive layer and a backing layer, and the pH in each layer is selected, such that absorption of buprenorphine is maximized. MUCOAbiESIVE , <.,xiMUCOAIJESIVE - T.M0COADHE5|VE Exemplary Embodiments of the Invention

Drugs covered by this patent

Patent Metadata

Patent number
AU2019206022A1
Jurisdiction
AU
Classification
—
Expires
2019-08-01
Drug substance claim
No
Drug product claim
No
Assignee
Biodelivery Sciences International Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.